Innovation After EASD: Market Trends and Clinical Takeaways: BI Replay
Join Bloomberg Intelligence pharma and biotech analysts Michael Shah and John Murphy as they examine the latest developments in obesity following the European Association for the Study of Diabetes (EASD) Conference. Gain insight into the current market landscape and emerging innovations on the horizon in the weight-loss market.